Last reviewed · How we verify
NCT03440957: OSTEO
Osteopathy Treatment for Cancer Pain Related to the Confinement to Bed
NA trial testing Osteopathic treatment in Cancer Patient Confined in the Bed in 22 participants. Completed in 2 February 2020.
2 February 2020
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 22 |
| Start date | 21 February 2018 |
| Primary completion | 2 February 2020 |
| Estimated completion | 2 February 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Osteopathic treatment
Conditions studied
- Cancer Patient Confined in the Bed — all drugs for Cancer Patient Confined in the Bed →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
18 and older, any sex, with Cancer Patient Confined in the Bed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Staying confined in the bed is frequent at the end of life. The cancer patients can also experiment this situation, and consequences are painful, with pain increasing with the time. This pain are related to the joints stiffing , muscles mass decreasing, and tendons retractions . The non pharmacological approach associated with the conventional treatments can be interesting to assess in this frails patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03440957
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteopathic treatment
Trials testing the same drug.
- NCT06822348 — Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot S · NA · not yet recruiting
- NCT07260422 — EVALUATION OF THE EFFECT OF OSTEOPATHIC TREATMENT ON CHRONIC NONSPECIFIC NECK PAIN · NA · completed
- NCT05726929 — Algology in Oncology Osteopathic Support (ALGOS) · NA · completed
- NCT04666415 — Impact of the Addition of a Specific and Personalized Body Approach by Osteopathic Treatment in the Care of Adolescents · NA · unknown
- NCT04125498 — The S-CARE Trial: Manual Treatment for C-sections Scars, a Pilot Study. · NA · suspended
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03440957 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 14 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03440957.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing